BayBio Lunch & Learn: Gaining Insight to Making “The Deal”

09/26/2013 11:00 a.m. - 12:30 p.m.

Life Sciences, Technology Transactions, and Emerging Companies + Venture Capital

HCP/BayBio Event Center
250 East Grand Avenue, Suite 26
South San Francisco, CA 94080

Stephen B. Thau

Stephen B. Thau

Speaking Engagement

The risks and costs of life sciences product development have become so high that few companies are willing to bear them on their own. As partnerships become vital, skill in deal-making has become almost as vital as scientific acumen for today’s pharma and biotech firms. Insight into the deal market is crucial for companies seeking to design advantageous deals.

During this Lunch & Learn, Stephen Thau, creator of BioMeter – a quarterly deal report that tracks deal activity across different stages of product development and different indications – will discuss its findings through the first half of 2013.

Attendees of the program will gain:

  • Insight into current market dynamics for licensing and collaboration deals
  • Understanding of the value of licensing assets at different stages of development
  • Understanding of market trends

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.